FDA Panel Recommends Riociguat (Adempas) for 2 Pulmonary Hypertension …

Published August 9, 2013

FDA Panel Recommends Riociguat (Adempas) for 2 Pulmonary Hypertension …

Filed under: drug treatment programs maryland

An advisory committee to the US Food and Drug Administration (FDA) voted unanimously yesterday to recommend riociguat (Adempas, Bayer Healthcare) for the indication of chronic thromboembolic pulmonary hypertension (CTEPH; World Health …
Read more on Medscape

Threshold Pharmaceuticals Initiates Phase 2 Study of TH-302 in Patients With …

Filed under: drug treatment programs maryland

SOUTH SAN FRANCISCO, CA–(Marketwired – Aug 8, 2013) – Threshold Pharmaceuticals, Inc. ( NASDAQ : THLD) today announced the initiation of a Phase 2 clinical trial to evaluate the efficacy and safety of TH-302, its investigational hypoxia-targeted drug …
Read more on Marketwire (press release)

High Blood Pressure Medication Linked to Breast Cancer

Filed under: drug treatment programs maryland

Public health implications of the finding could be huge, considering the sheer number of people taking this class of drug — 98 million prescriptions for calcium-channel blockers are filled in the United States each year, the researchers said …
Read more on Everyday Health